Bellus Medical said today it won CE Mark approval for its SkinPen microneedling cartridge, with clearance to treat surgical scars.
The microneedling device uses collagen induction therapy to treat cosmetic conditions, the Addison, Texas-based company said. A rollout is planned in Europe during this year.
“Receiving the CE Mark represents a significant milestone for Bellus Medical. When we started Bellus Medical in 2012, our goal was to create a company that was patient-focused, as well as product-focused. Today, we are an industry leader, a trusted provider, and now we can share that same level of service and commitment with our new partners in Europe. The aesthetics community has eagerly anticipated the expected quality improvements of devices in the microneedling category, and we look forward to the SkinPen brand’s broad adoption in Europe. Providing practices in Europe with a safe, reliable and effective device is an accomplishment we are proud of. We are committed to providing cutting-edge, safe and high-quality devices, and we are thrilled about the opportunity to expand this commitment across Europe,” prez & CEO Joe Proctor said in a press release.